Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
Clinical trial NCT04058028 · COMPLETED
Trial details
- NCT number
- NCT04058028
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2023-07-25
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.